Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9434697 Pyrimidine FGFR4 inhibitors

Patent 9434697 was granted and assigned to Eisai on September, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Eisai

Current Assignee

Eisai

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

94346970

Patent Inventor Names

Ming-Hong Hao0

Takashi Satoh0

Anand Selvaraj0

Dominic Reynolds0

John Wang0

Sudeep Prajapati0

Date of Patent

September 6, 2016

Patent Application Number

150006590

Date Filed

January 19, 2016

Patent Citations Received

‌

US Patent 11833119 Combination therapies for the treatment of hepatocellular carcinoma

Patent Primary Examiner

‌

Kamal Saeed

Patent abstract

Provided herein are compounds of Formula I useful as FGFR4 inhibitors, as well as methods of use of the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9434697 Pyrimidine FGFR4 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API